Available from: Ray-Coquard I, Leary A, Pignata S, Cropet C, Gonzlez-Martin A, Marth C, et al
The trial randomized over 1,600 participants across the U.S., Argentina, Australia, Brazil, China, Czechia, Germany, Greece, India, South Korea and Puerto Rico to receive various doses of orforglipron or placebo along with healthy diet and physical activity
*Only NASH resolution is presented as a relative risk with a 95% confidence interval, which favors greater value in this study
SUAD This was my first time seeking treatment outside the NHS Mandi was exceptionally knowledgeable, friendly and put me complete easy
Early identification of poor responders may reduce unnecessary health care costs, adverse effects, and prolonged ineffective treatment